Eli Lilly LLY announced plans to acquire SiteOne Therapeutics to expand its pain pipeline. Moderna MRNA announced that the ...

The Nifty 50 slipped 63 points, or 0.3%, to close at 24,752, while the Sensex shed 240 points, or 0.29%, ending at 81,312.

There’s already overlap in the pharmaceutical industry between the U.K. and Pennsylvania, but details in Trump’s trade deal with the island still need to be hashed out.

The only shingles vaccine on the market in South Africa was discontinued last year. A newer and better vaccine is being used ...

Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of GSK’s Blenrep (belantamab mafodotin) ...

However, Bayer's top-selling pharma product Xarelto (rivaroxaban), an anticoagulant ... Other European pharma groups, including AstraZeneca, GSK, Roche, and Sanofi, have all also upgraded their ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 31-03-2025, ...

Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

A month after the FDA lifted its clinical hold on GSK’s vaginal yeast infection drug Brexafemme (ibrexafungerp), the ...

GSK Plc halted a trial following positive results for an oral antibiotic to treat complicated urinary tract infections that could replace an intravenous medicine that is typically used.

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

GSK PLC closed 18.99% short of its 52-week high of £17.88, which the company achieved on May 28th.